… A large number of economic evaluations have been published that assess alternative
possible human papillomavirus (HPV) vaccination strategies. Understanding differences in the …

… cost-effective? In this study, the authors found that the nonavalent vaccine will likely be the
most cost-effective … against HPV-types 16/18 is comparable to that of the quadrivalent vaccine. …

… papillomavirus vaccination is cost-effective before vaccine … evaluations of human
papillomavirus vaccination in low and middle … vaccination is likely to be cost-effective and possibly …

… cost-effectiveness studies have evaluated the optimum pricing of the human papillomavirus
(HPV) nonavalent vaccine … that a key driver of cost-effectiveness is the reduction in screen-…

… vaccination is a cost effective strategy at the population level, as the ICERs across most
vaccination … for Singapore, and the vaccine strategies were more cost-beneficial under a wide …

… A nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women
and men up to age 45 years in the United States. The cost-effectiveness of HPV vaccination for …

… For each sensitivity analysis, we calculated the cost-effectiveness ratio with the assumed
vaccination costs and the threshold price per dose for vaccination to be cost-effective with an …

… In addition, this study aims to examine the cost-effectiveness of the 9-valent vaccine when
boys … evidence of general trends on the ongoing cost-effectiveness evaluation of HPV vaccine. …

… after reviewing evidence including cost effectiveness modelling.Here we present a cost
effectiveness analysis of two versus three dose human papillomavirus vaccination; this analysis …

… published cost–effectiveness studies of human papillomavirus (HPV) vaccines along a …
disease, cervical cancer screening and HPV vaccination. For each structural aspect examined, …